findmyKOL
Clinical trialNCT01995578CompletedPhase 2Interventional

Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse

SponsorMemorial Sloan Kettering Cancer CenterEnrollment32Acute Myelogenous Leukemia (AML)Myelodysplastic Syndromes (MDS)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Memorial Sloan Kettering at Basking Ridge (consent and Follow-Up)

    Basking Ridge, New Jersey, United States

  • Memorial Sloan Kettering Monmouth (consent and Follow-Up)

    Middletown, New Jersey, United States

  • Memorial Sloan Kettering Bergen (consent and Follow-Up)

    Montvale, New Jersey, United States

  • Memorial Sloan Kettering Commack (consent and Follow-Up)

    Commack, New York, United States

  • Memorial Sloan Kettering Westchester (consent and Follow-Up)

    Harrison, New York, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

  • Memorial Sloan Kettering Nassau (consent and Follow-Up)

    Rockville Centre, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2013
Primary completion
27 Sept 2023
Completion
27 Sept 2023
Last update posted
22 May 2024
Registered enrollment
32
Registry id
NCT01995578
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.